Startups

AOA Dx logo

AOA Dx

AOA Dx develops blood-based diagnostics for early detection of ovarian cancer using glycolipid biomarkers and its GlycoLocate platform.

Founded 2020

Team

Anna JeterCo-founder
Anna JeterCo-founder and CEO

Investments